Discover the groundbreaking FDA approval of ZEVASKYN™, the first gene therapy designed specifically for Recessive Dystrophic Epidermolysis Bullosa (RDEB). This innovative treatment offers new hope to patients suffering from this debilitating skin condition, addressing the root causes and transforming lives. Learn more about its mechanism, efficacy, and the support available for patients.

Discover how EPA Administrator Lee Zeldin is transforming environmental policy with 100 initiatives aimed at cleaner air, water, and land. Learn about groundbreaking efforts to combat PFAS contamination, restore hazardous Superfund sites, and ensure a healthier future for American communities.